Applications, hearings, determinations, etc.: Cody Laboratories, Inc.,

[Federal Register: October 25, 2004 (Volume 69, Number 205)]

[Notices]

[Page 62295]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr25oc04-89]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances Notice of Application

Pursuant to 21 CFR 1301.33(a), this is notice that on April 20, 2004, Cody Laboratories, Inc., 301 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed:

Drug

Schedule

Amphetamine (1100).........................................

II Methamphetamine (1105).....................................

II Amobarbital (2125).........................................

II Pentobarbital (2270).......................................

II Secobarbital (2315)........................................

II Cocaine (9041).............................................

II Oxycodone (9143)...........................................

II Dihydromorphine (9145).....................................

II Hydromorphone (9150).......................................

II Diphenoxylate (9170).......................................

II Meperidine (9230)..........................................

II Oxymorphone (9652).........................................

II Sufentanil (9740)..........................................

II Fentanyl (9801)............................................

II

The company plans to manufacture bulk materials for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than December 27, 2004.

Dated: October 18, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 04-23767 Filed 10-22-04; 8:45 am]

BILLING CODE 4410-09-P